Zandee, W. T., Hofland, J., & de Herder, W. W. (2021). Should everolimus be stopped after radiological progression in metastatic insulinoma? A "pro" point of view. Endocrine. https://doi.org/10.1007/s12020-020-02570-4

Merola, E., Alonso Gordoa, T., Zhang, P., Al-Toubah, T., Pellè, E., Kolasińska-Ćwikła, A., Zandee, W., Laskaratos, F., de Mestier, L., Lamarca, A., Hernando, J., Cwikla, J., Strosberg, J., de Herder, W., Caplin, M., Cives, M., & van Leeuwaarde, R. (2020). Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? The Oncologist, 1-8. [onco.13633]. https://doi.org/10.1002/onco.13633

Links, T. P., van der Boom, T., Zandee, W. T., & Lefrandt, J. D. (2020). Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroid cancer. Endocrine Connections. https://doi.org/10.1530/EC-20-0539

Merola, E., Zandee, W. T., de Mestier, L., Klumpen, H-J., Makulik, K., Geboes, K., van Velthuysen, M-L., Couvelard, A., Cros, J., van Eeden, S., Hoorens, A., Stephenson, T., Zajęcki, W., de Herder, W. W., & Munir, A. (2020). Histopathological Revision for Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in Expert Centers: Does it Make the Difference? Neuroendocrinology, 111(1-2), 170-177. https://doi.org/10.1159/000507082

Refardt, J., Zandee, W. T., Brabander, T., Feelders, R. A., Franssen, G. J. H., Hofland, L. J., Christ, E., de Herder, W. W., & Hofland, J. (2020). Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging. Endocrine-Related cancer, 27(11), 615-624. https://doi.org/10.1530/ERC-20-0340

Zandee, W. T., van der Zwan, J. M., de Herder, W. W., & van Velthuysen, M-L. F. (2020). Importance of complete pathology reporting for neuroendocrine carcinoma: WHO guidelines are a good start but not enough. Neuroendocrinology, 110(11-12), 994-1000. https://doi.org/10.1159/000505920

Zandee, W. T., Feelders, R. A., Smit Duijzentkunst, D. A., Hofland, J., Metselaar, R. M., Oldenburg, R. A., van Linge, A., Kam, B. L. R., Teunissen, J. J. M., Korpershoek, E., Hendriks, J. M., Abusaris, H., Slagter, C., Franssen, G. J. H., Brabander, T., & De Herder, W. W. (2019). Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE. European Journal of Endocrinology, 181(1), 45-53. https://doi.org/10.1530/EJE-18-0901

Zandee, W. T., Brabander, T., Blažević, A., Kam, B. L. R., Teunissen, J. J. M., Feelders, R. A., Hofland, J., & de Herder, W. W. (2019). Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors. Journal of Clinical Endocrinology and Metabolism, 104(4), 1336-1344. https://doi.org/10.1210/jc.2018-01991

Carlsen, E. A., Fazio, N., Granberg, D., Grozinsky-Glasberg, S., Ahmadzadehfar, H., Grana, C. M., Zandee, W. T., Cwikla, J., Walter, M. A., Oturai, P. S., Rinke, A., Weaver, A., Frilling, A., Gritti, S., Arveschoug, A. K., Meirovitz, A., Knigge, U., & Sorbye, H. (2019). Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study. Endocrine-Related cancer, 26(2), 227-239. https://doi.org/10.1530/ERC-18-0424

Hofland, J., Herrera-Martínez, A. D., Zandee, W. T., & de Herder, W. W. (2019). Management of carcinoid syndrome: a systematic review and meta-analysis. Endocrine-Related cancer, 26(3), R145-R156. https://doi.org/10.1530/ERC-18-0495

Hofland, J., Zandee, W. T., & de Herder, W. W. (2018). Role of biomarker tests for diagnosis of neuroendocrine tumours. Nature reviews endocrinology, 14(11), 656-669. https://doi.org/10.1038/s41574-018-0082-5

Blažević, A., Zandee, W. T., Franssen, G. J. H., Hofland, J., van Velthuysen, M-L. F., Hofland, L. J., Feelders, R. A., & de Herder, W. W. (2018). Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours. Endocrine-Related cancer, 25(3), 245-254. https://doi.org/10.1530/ERC-17-0282

Rindi, G., Klersy, C., Albarello, L., Baudin, E., Bianchi, A., Buchler, M. W., Caplin, M., Couvelard, A., Cros, J., de Herder, W. W., Delle Fave, G., Doglioni, C., Federspiel, B., Fischer, L., Fusai, G., Gavazzi, F., Hansen, C. P., Inzani, F., Jann, H., ... Falconi, M. (2018). Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study. Neuroendocrinology, 107(4), 375-386. https://doi.org/10.1159/000494355

Zandee, W. T., & de Herder, W. W. (2018). The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines. Neuroendocrinology, 106(4), 357-365. https://doi.org/10.1159/000486096

de Hosson, L. D., van Veenendaal, L. M., Schuller, Y., Zandee, W. T., de Herder, W. W., Tesselaar, M. E. T., Klumpen, H. J., & Walenkamp, A. M. E. (2017). Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework. Annals of Oncology, 28(12), 3022-3027. https://doi.org/10.1093/annonc/mdx547

Zandee, W. T., van Adrichem, R. C., Kamp, K., Feelders, R. A., van Velthuysen, M-L. F., & de Herder, W. W. (2017). Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours. Clinical Endocrinology, 87(2), 165-170. https://doi.org/10.1111/cen.13364

Zandee, W. T., Alsma, J., Birkenhäger, T. K., den Meiracker, A. H. VAN., van Hoek, M., & Versmissen, J. (2017). Hypertensie en orthostatische hypotensie bij gebruik van monoamine-oxidase(MAO)-remmers1. Tijdschrift voor Psychiatrie, 59(6), 366-371.

Zandee, W. T., Kamp, K., van Adrichem, R. C. S., Feelders, R. A., & de Herder, W. W. (2016). Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours. European Journal of Endocrinology, 175(5), 361-6. https://doi.org/10.1530/EJE-16-0392

Verbeek, H. H. G., Meijer, J. A. A., Zandee, W. T., Kramp, K. H., Sluiter, W., Smit, J. W., Kievit, J., Links, T. P., & Plukker, J. T. M. (2015). Fewer Cancer Reoperations for Medullary Thyroid Cancer After Initial Surgery According to ATA Guidelines. Annals of Surgical Oncology, 22(4), 1207-1213. https://doi.org/10.1245/s10434-014-4115-6